GlassScriptPhysician profile
Travis C Washington
NPI 1932561024
$38,653.57
in general payments reported to CMS, 2019-2025
25 companies · $14K in 2025
The $14K reported for 2025 was more than what 89% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $827 · 2021: $589 · 2022: $5,771 · 2023: $11K · 2024: $6,293 · 2025: $14K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $9,748 · Travel and Lodging: $9,045 · Food and Beverage: $7,696 · Education: $4,978.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $9,748.30 |
| Travel and Lodging | $9,045.08 |
| Food and Beverage | $7,695.75 |
| Education | $4,977.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kuros Biosciences USA, INC | $9,211.10 | 2024-2025 | Magnetos |
| Nevro Corp. | $7,459.72 | 2023-2024 | Senza |
| Stryker Corporation | $5,169.71 | 2022-2025 | Cascadia Interbody System, Everest Spinal System, Simpliciti |
| Globus Medical, INC. | $3,168.46 | 2022-2025 | Corbel, Senza, Vyrsa V1 |
| Expanding Innovations, INC. | $3,000.04 | 2025 | X-Pac |
| Medtronic, INC. | $2,653.28 | 2021-2025 | Prestige LP Cervical Disc System, Anteralign Spinal System With Titan Nanolock Surface Technology, Atlantis Anterior Cervical Plate System |
| Highridge Medical LLC | $1,991.39 | 2024 | The Tether, Timberline, Mobi-C Plug & Fit US |
| Orthofix Medical, INC. | $1,876.58 | 2025 | Lattus, Fathom |
| Si-Bone, INC. | $1,394.74 | 2022-2025 | |
| Medtronic USA, INC. | $826.83 | 2019 | |
| Centinel Spine, LLC | $364.44 | 2022-2023 | Prodisc C Vivo, Prodisc L |
| Kerecis Limited | $188.40 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Pinnacle, INC | $174.65 | 2023-2024 | |
| Abbott Laboratories | $150.59 | 2023 | Proclaim |
| Convatec INC. | $149.98 | 2023 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ctl Medical Corporation | $141.00 | 2024 | Spinal |
| Smith+Nephew, INC. | $128.26 | 2024 | Firstpass, Bone Anchors With Arthroscopic Delivery System, Healicoil |
| Davol INC. | $126.63 | 2024 | |
| Sanara Medtech INC. | $126.18 | 2024 | Celleraterx |
| Vertex Pharmaceuticals Incorporated | $124.74 | 2025 | |
| Spineology INC. | $87.52 | 2023 | Optimesh Expandable Interbody Fusion System |
| Boston Scientific Corporation | $76.96 | 2023 | |
| Cerapedics INC. | $30.51 | 2023 | I-Factor Peptide Enhanced Bone Graft |
| Providence Medical Technology, INC. | $18.02 | 2023 | |
| Theragen, INC. | $13.84 | 2024 | Actastim-S |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$5,696.60 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Travis Washington listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.